Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortChemotherapy in tablet form.Cuts off a tumour's blood supply.
Body systemCancerCancer
Drug classAntimetabolitesTargeted antibodies
SupplyPrescription onlyWHO essential medicinePrescription only
Main usesBowel cancer, Breast cancer, Stomach and oesophageal cancer, With radiotherapy for rectal cancerBowel cancer, Lung cancer, Ovarian and cervical cancer, Glioblastoma, Wet macular degeneration (off-label eye injections)
How it worksBecomes chemotherapy mainly inside cancer tissue.Stops tumours growing the blood vessels they need.
Starts working——
Half-life—About 20 days
Typical adult doseUsually 1,000–1,250 mg/m² twice a day for 14 days of each 21-day cycle.5–15 mg/kg IV every 2–3 weeks depending on cancer.
FormsTabletIV infusion, Intravitreal injection (ophthalmic forms in some countries)
Common side effectsSore, red, peeling hands and feet, Diarrhoea, Nausea, TirednessHigh blood pressure, Protein in urine, Nosebleeds, Tiredness
Serious side effectsSevere diarrhoea and dehydration, Low blood counts, Fatal toxicity with DPD deficiency, Chest pain (coronary spasm)Bowel perforation, Bleeding, Poor wound healing, Clots
Don't take if——
Alcohol——
PregnancyUsually avoidedCan harm the fetus.Usually avoidedContraception for 6 months after.
Breastfeeding——
In use since19982004
Brand namesUnited States: XelodaUnited Kingdom: Xeloda, EcansyaIndia: Capegard, XelodaUnited States: Avastin, Mvasi, ZirabevUnited Kingdom: Avastin, AlymsysIndia: Bevatas, Abevmy
Legal status——
ATC codeL01BC06L01FG01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker